BioSpace News Archive

Business

NuVasive Announces Second Quarter 2019 Financial Results

NuVasive, Inc., the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, announced financial results for the quarter ended June 30, 2019.

July 30, 2019
·
23 min read
Business

Kala Pharmaceuticals to Report Second Quarter 2019 Financial Results and Host Conference Call

Kala Pharmaceuticals, Inc. (NASDAQ:KALA), a biopharmaceutical company focused on the development and commercialization of therapeutics using its proprietary AMPPLIFY™ mucus-penetrating particle (MPP) Drug Delivery Technology, today announced that it will report second quarter 2019 financial results

July 30, 2019
·
1 min read
Biotech Bay

Gilead Sciences Announces Third Quarter 2019 Dividend

Gilead Sciences, Inc. (Nasdaq: GILD) today announced that the company’s Board of Directors has declared a cash dividend of $0.63 per share of common stock for the third quarter of 2019.

July 30, 2019
·
1 min read
Business

AtriCure Reports Second Quarter 2019 Financial Results

AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in treatments for atrial fibrillation (Afib) and left atrial appendage (LAA) management, today announced second quarter 2019 financial results.

July 30, 2019
·
11 min read
BioMidwest

Exicure Announces Proposed Public Offering of Common Stock and Uplisting to Nasdaq Capital Market

Exicure, Inc. (OTCQB: XCUR), a pioneer in gene regulatory and immunotherapeutic drugs utilizing spherical nucleic acid (SNA™) constructs, announced today that it intends to offer and sell shares of its common stock in an underwritten public offering

July 30, 2019
·
4 min read
Business

QIAGEN reports full results for second quarter and first half of 2019

QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) announced today full results of operations for the second quarter and first half of 2019, achieving the outlook set for net sales growth and adjusted diluted earnings per share at constant exchange rates (CER).

July 30, 2019
·
2 min read
Business

Veracyte Announces Second Quarter 2019 Financial Results

Veracyte, Inc. (Nasdaq: VCYT) today announced financial results for the second quarter ended June 30, 2019 and provided an update on recent business highlights.

July 30, 2019
·
12 min read
Deals

IQVIA Announces Pricing of Offering of Senior Notes - July 30, 2019

IQVIA Holdings Inc. announced that its wholly owned subsidiary, IQVIA Inc., priced an offering of €720,000,000 in aggregate principal amount of senior notes due 2028.

July 30, 2019
·
2 min read
Business

Castlight Health Announces Second Quarter 2019 Results

Updates Full Year 2019 Guidance & Announces Management Changes

July 30, 2019
·
15 min read
Pharm Country

BioReference Notifies Patients in AMCA Incident

BioReference Laboratories, Inc. (“BioReference”) announced today that it is mailing letters to some of its patients whose information may have been included in the American Medical Collection Agency (“AMCA”) security incident previously announced.

July 30, 2019
·
1 min read